Trifecta Capital Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1962615 NORTHBROOK, IL

Position in VRTX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$8,317,743

+$835,073 QoQ

Shares Held

16,745

-0.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

1.23%

of 13F equity value

Holder Rank

#398

of 1,746 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $8,537,516 across 9 Biotechnology names. VRTX ranks #1 (97.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	16,745	$8,317,743
2	DRTS	Alpha Tau Medical Ltd.	8,750	$110,075
3	TWST	Twist Bioscience Corp	610	$62,756
4	CAI	Caris Life Sciences, Inc.	2,100	$37,422
5	ARMP	Armata Pharmaceuticals, Inc.	714	$4,626
6	BYSI	BeyondSpring Inc.	1,500	$2,625
7	ARGX	Argenx SE	2	$1,855
8	TVTX	Travere Therapeutics, Inc.	4	$227

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,317,743	16,745	-0.1%	Shares	Sole	2026-08-03
2026-03-31	$7,482,670	16,757	+1.6%	Shares	Sole	2026-05-01
2025-12-31	$7,479,079	16,497	+4.2%	Shares	Sole	2026-01-30
2025-09-30	$6,200,836	15,833	+3.2%	Shares	Sole	2025-11-03
2025-06-30	$6,829,368	15,340	+5.5%	Shares	Sole	2025-07-23
2025-03-31	$7,048,313	14,538	+4.1%	Shares	Sole	2025-04-21
2024-12-31	$5,623,705	13,965	+3.2%	Shares	Sole	2025-02-04
2024-09-30	$6,294,857	13,535	+1.6%	Shares	Sole	2024-10-16
2024-06-30	$6,241,475	13,316	+7.7%	Shares	Sole	2024-08-07
2024-03-31	$5,167,021	12,361	+4.4%	Shares	Sole	2024-04-16
2023-12-31	$4,815,543	11,835	+3.0%	Shares	Sole	2024-01-25
2023-09-30	$3,993,793	11,485	+6.3%	Shares	Sole	2023-11-01
2023-06-30	$3,800,628	10,800	+10.1%	Shares	Sole	2023-08-14
2023-03-31	$3,090,836	9,810	+115.6%	Shares	Sole	2023-05-09
2022-12-31	$1,313,949	4,550	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.